The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
about
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaNanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatmentLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaFunctionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitroBiomedical Applications of Biodegradable Polymers.Multifunctional polymeric micelles for delivery of drugs and siRNA.Nanobubbles for enhanced ultrasound imaging of tumors.Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Smart polymeric nanoparticles for cancer gene delivery.Nanotechnology for energy-based cancer therapiesEfficient delivery of NF-κB siRNA to human retinal pigment epithelial cells with hyperbranched cationic polysaccharide derivative-based nanoparticlesSynthesis of polysaccharide-block-polypeptide copolymer for potential co-delivery of drug and plasmid DNA.Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor modelEnhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin.BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA DeliveryDelivery of intracellular-acting biologics in pro-apoptotic therapies.Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.Utilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles.Image-guided nanosystems for targeted delivery in cancer therapy.Recent progress in copolymer-mediated siRNA delivery.Cationic polymers and their therapeutic potential.Recent advances in delivery of drug-nucleic acid combinations for cancer treatmentNanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.Materials innovation for co-delivery of diverse therapeutic cargos.Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.Drug and gene co-delivery systems for cancer treatment.Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer.Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.Tackling breast cancer chemoresistance with nano-formulated siRNA.Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy.Copolymer of poly(ethylene glycol) and poly(L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.
P2860
Q26823523-C7A93F60-C1A1-42AF-AC4E-0A62C7D373A3Q26866566-35FA9442-7D8F-4525-919F-ACF93CDACA5DQ28068437-9C5A70C6-72C6-4FB1-8C3B-C26D4459FA2FQ28488394-0CA9BF4F-3A54-47BB-8D21-DCC8C02A70E2Q30426452-469F818B-78EA-4FE7-AAA3-35FECEB283B4Q30438973-1400CB2C-94A4-4BA6-A70E-7A188F45ED94Q30469828-5F51CDC6-29C2-46E4-8CBF-79484C843ACDQ33627888-E13E81D3-4227-4B06-B4C5-5B9E81ECAC61Q34440323-E0753C59-2B78-44DD-BE5C-A24260144530Q34446374-5CAA9B0B-2DE0-4C8F-AF9D-F59240828384Q34622662-30C1594A-0418-4852-B745-F590C1A0C9F6Q35057532-FD7D2E2F-DE96-41CE-8907-D95E86A50B77Q35264028-1BB9C99B-9918-4C9B-B5F4-56399E5BA843Q35411181-FB740E9A-1F06-4C00-B8D5-1B2496465333Q35575232-21C9AC8D-7289-404D-8BEC-5D1F15EEE74DQ35924301-6E658E8C-6091-4574-B881-2202F25A5FE7Q35979171-10EB4506-3665-4BB8-965D-3FB5FD95C6F0Q36148627-5FADEB68-6914-4EF1-A434-963D50BCD941Q36167369-522CCB09-6B59-40FD-BF39-BB4E9EC1FD41Q36588920-67976ED5-F0C0-4DD2-B2C7-045F67F27F7FQ36748360-4800934A-5173-4847-B37E-A23C67284C39Q36980441-BFC9939B-0907-4A6F-B4F3-0356DAEA873FQ38011794-8C695E3A-20CB-44B4-B121-9E9DEC4D1147Q38023545-A491DF5F-133D-4012-9E6A-F6B2AFDA248CQ38033969-15638266-EF52-4E6A-819D-825902A84C10Q38102522-629F3726-EECC-4E07-AD5E-D552F584BFEAQ38183852-ACA51034-8294-4DC4-BA4C-3A7AE17B552EQ38191832-E821351D-5085-47A6-8B0F-18312C0AF6F7Q38211033-AB679E3A-3A5C-4DC2-9F82-52620C2458B9Q38271422-FE983FA4-33D9-45D4-935F-B74B2D7F0957Q38451918-1915A0B5-1F76-435E-8133-1F5FEE1B87A4Q38555082-E2F88D66-D243-4A77-A34A-2ED7262654CDQ38556764-C778A98C-1EDC-4ACC-9127-001FAD6ACEDAQ38787321-E0935EF1-28DE-468F-BEBA-F97642398774Q38833453-FA840426-E039-461F-9EC4-1F5D5F45BE47Q38889403-1608CD85-0AA8-41FB-8544-2570671D2FBFQ38959517-EDA83975-94A4-4FE2-95E2-E7512A6E36C4Q39011686-AAC4824F-B585-4CA8-910A-8172BD04FA5DQ39042525-BE6ED8BC-25CC-4D1D-957C-EFAE56DB5683Q39113994-D6453706-F579-4B35-9F4C-B61C35E34481
P2860
The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The synergistic effect of hier ...... red into hepatic cancer cells.
@en
The synergistic effect of hier ...... red into hepatic cancer cells.
@nl
type
label
The synergistic effect of hier ...... red into hepatic cancer cells.
@en
The synergistic effect of hier ...... red into hepatic cancer cells.
@nl
prefLabel
The synergistic effect of hier ...... red into hepatic cancer cells.
@en
The synergistic effect of hier ...... red into hepatic cancer cells.
@nl
P2093
P1433
P1476
The synergistic effect of hier ...... ered into hepatic cancer cells
@en
P2093
P304
P356
10.1016/J.BIOMATERIALS.2010.11.061
P577
2010-12-24T00:00:00Z